News
Sygnature expands capabilities with acquisition of Alderley Oncology
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of...
News
Messe Frankfurt to focus on highlighting strong anti-counterfeiting measures in wake of Covid-19
As demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and counterfeit medicines in the...
Packaging & Labelling
Serialization: Syntegon joins OPEN-SCS Group
Syntegon Technology recently joined the Open Serialization Communication Standard (OPEN-SCS) Group. Joint goals include the fight against pharmaceutical counterfeiting and the establishment of interoperable...
Press Releases
CPhI Worldwide 2020 Implements new ‘Informa AllSecure Standard’
CPhI Worldwide – organised by Informa Markets – will this year be organised in accordance with Informa’s AllSecure health and safety standard in response...
Press Releases
Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX
Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of EnvisiX to address the budgeting challenges experienced by global...
News
WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced the appointment of Dr. David Chang as Chief...
Press Releases
AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis
AbbVie , a research-based global biopharmaceutical company, announced that it has submitted applications for a new indication to the U.S. FDA and European Medicines...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read